I enjoy and take pride in working with entrepreneurs and investors driven for production, innovation and success.

Experience

Cooley Guides b8ta on Key Transactions

March 5, 2020

Cooley advised retail tech company b8ta on multiple strategic deals, including its partnership with Middle Eastern luxury retailer Chaloub Group to bring b8ta stores worldwide. Cooley partner Kevin Rooney led the team advising b8ta on the transactions. 

Read more

Related contacts

Kevin Rooney
Partner, San Francisco
Peter Burns
Of Counsel, Palo Alto
Paul Roberts
Of Counsel, San Francisco
Howard Morse
Partner, Washington, DC
Caitlin Courtney
Partner, Palo Alto
Allison Pang
Associate, Palo Alto
Sale Kwon
Partner, Palo Alto
Jeramie Perez
Senior Paralegal, Palo Alto

Related Practices & Industries

Hanwha Systems Investment in Karem Aircraft $25 Million Series A

January 11, 2020

Cooley advised Hawha Systems on its investment in the $25 million Series A financing of Overair, a spin-off of Karem Aircraft, an electric takeoff and landing (eVTOL) aircraft developer.

Related contacts

Rowook Park
Partner, San Diego
Rama Padmanabhan
Partner, San Diego
Matt Hallinan
Partner, Santa Monica
Charles Haley
Partner, Palo Alto
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Jonathan Rivinus
Partner, Colorado
Sale Kwon
Partner, Palo Alto
Emily Iannarelli
Associate, Palo Alto
Kevin King
Partner, Washington, DC
Dillon Martinson
Special Counsel, Washington, DC
Daniel Y. Lee
Associate, Palo Alto

Related Practices & Industries

Rapt Therapeutics – $38 Million IPO

November 1, 2019

Cooley advised Rapt Therapeutics on its $38.4 million initial public offering of 3,200,000 shares of common stock. Rapt Therapeutics, whose securities now trade on Nasdaq Global Market under the symbol “RAPT,” is clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Partner Michael Tenta led the Cooley team.

Related contacts

Sale Kwon
Partner, Palo Alto
Noel Ripberger-Scheick
Associate, Palo Alto
Isabelle Mackesey
Associate, Washington, DC

Related Practices & Industries

Cooley Advised Jazz Pharmaceuticals on Rule 144A Offering of $575 Million of Exchangeable Senior Notes

August 17, 2017

Cooley advised Ireland-based Jazz Pharmaceuticals plc (Nasdaq: JAZZ) on its Rule 144A offering of $575 million of exchangeable senior notes due 2021. Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing differentiated products that address unmet medical needs.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Chadwick Mills
Partner, San Francisco
Francis Wheeler
Partner, Colorado
Sale Kwon
Partner, Palo Alto
Jason Savich
Partner, San Francisco
Amanda Fant
Associate, New York
Sepideh Mousakhani
Partner, Palo Alto

Related Practices & Industries

Xenon Pharmaceuticals Completes Initial Public Offering

November 21, 2014

Cooley advised the underwriters on Xenon Pharmaceuticals' initial public offering. Xenon is a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan indications. Xenon has built a core-enabling discovery platform for the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies. The company now trades on the Nasdaq Global Market under the symbol "XENE."

Jefferies and Wells Fargo Securities acted as the joint book-running managers and Canaccord Genuity acted as co-manager for the offering.

Related contacts

Charlie Kim
Partner, San Diego
Drew Williamson
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Bill Christiansen
Partner, Seattle
Natasha Leskovsek
Of Counsel, Washington, DC
Jonie Ing Kondracki
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Sale Kwon
Partner, Palo Alto
Megan Arthur Schilling
Partner, San Diego

Related Practices & Industries

View more

Admissions and credentials

California

Rankings and accolades

The Legal 500 US: Next Generation Partner for Venture Capital and Emerging Companies (2021 – 2024)

Memberships and affiliations

American Bar Association (ABA)